Syringe and Needle Market Size, Share & Trends Analysis | Global | 2026-2032 | Includes: Syringes and Needles

Global Syringe and Needle Market Report to 2032

The global syringe and needle market was valued at $4.9 billion in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 1.9%, reaching $5.6 billion by 2032.

This report covers the global syringe and needle market, including syringes and needles used across hospital, outpatient, vaccination, infusion, medication delivery, and routine care settings.

The syringe segment includes conventional and safety syringes. The needle segment includes conventional needles, safety needles, and blunt fill needles.

Market growth is supported by conversion to safety products, rising disease incidence, and the continued need for reliable low-cost injection devices. However, group purchasing organizations and the use of needleless devices continue to place downward pressure on pricing and long-term market expansion.

Market Overview

The global syringe and needle market includes high-volume consumable products used for medication delivery, injections, blood draws, preparation, and clinical procedures across healthcare settings.

• The market is divided into two main segments: syringes and needles. The syringe segment includes conventional syringes and safety syringes, while the needle segment includes conventional needles, safety needles, and blunt fill needles.

Ongoing efforts to reduce needlestick injuries continue to shape product selection. Regulatory pressure and occupational safety programs have accelerated adoption of safety-engineered syringes and increased the use of needleless connectors for vascular access.

Despite the growth of needleless systems, broad displacement of conventional syringes and needles has not occurred. Their low unit cost, reliability, clinician familiarity, and broad availability ensure that syringes and needles remain deeply embedded in routine care.

Market Drivers

Conversion to Safety Products

Conversion to safety products remains one of the most important drivers of the syringe and needle market. Occupational safety regulations and legislation, including the Needlestick Safety and Prevention Act, have supported widespread adoption of safety-engineered products.

The acute care market has achieved a high degree of safety conversion due to inspection, enforcement, and stronger institutional purchasing standards. Safety syringes and safety needles are now widely used in hospitals and other settings where needlestick injury prevention is a major priority.

Safety products carry a significant price premium over conventional products. This higher ASP has increased the value of the market and helped offset pricing pressure in basic syringe and needle categories.

Ongoing conversion in alternate care sites, outpatient settings, emerging markets, and lower-penetration regions is expected to support future growth. While many developed hospital markets are already highly converted, the global transition is not fully complete.

Increasing Disease Incidence

Increasing disease incidence is another major driver. The incidence of chronic diseases such as diabetes and cancer is expected to rise as the global population ages and obesity rates increase.

These diseases often require medical treatments that rely on syringes and needles. Diabetes can involve frequent injections and medication management, while cancer care may involve repeated medication preparation, administration, and supportive care.

The obese population has a higher risk of developing diabetes, creating additional long-term demand for injection-related products. As chronic disease treatment volumes increase, demand for syringes and needles is expected to remain steady across both hospital and non-hospital care settings.

This driver is especially important because syringes and needles are used across many procedures and treatment pathways. Even where device pricing is under pressure, high utilization volumes support overall market stability.

Reliability and Familiarity

Syringes and needles continue to benefit from reliability, simplicity, and clinician familiarity. These products are inexpensive, widely available, and easy to use in a broad range of care environments.

Needle-free injection technologies, including gas-powered and jet-based systems, continue to be researched. However, these alternatives have not broadly replaced syringes and needles in routine care.

In many clinical workflows, syringes and needles remain the most practical option. Their established role in medication delivery, vaccination, preparation, and injection-based care supports continued growth through 2032.

Market Limiters

Group Purchasing Organizations

Group purchasing organizations are a major limiter of the syringe and needle market. More than 80% of syringes and needles in the acute care market are purchased through GPOs.

These organizations increase the bargaining power of hospitals and help reduce the price paid for medical products. While this benefits healthcare providers, it places strong downward pressure on ASPs.

GPOs also make it difficult for smaller manufacturers to enter the market. High-volume requirements and price discounts can prevent smaller companies from bidding on contracts, limiting their ability to gain share.

Although GPOs help hospitals reduce costs, they can discourage innovation and decrease total market value. This pricing environment will continue to limit growth over the forecast period.

Use of Needleless Devices

The drive to reduce needlestick injuries has supported safety syringes, but it has also increased the use of needleless devices. Needleless connectors, closed IV delivery systems, and pumps can reduce the need for traditional needle-based delivery in certain inpatient workflows.

Catheters and tubing often include Luer-lock connectors, allowing infusion through syringes without needles. Luer-lock systems can also support the use of pumps instead of manual syringe delivery.

In general, preventing needlestick injuries is best achieved by eliminating the use of needles altogether. This has created continued interest in needleless devices and needle-free injection technologies.

However, the low cost and ease of use of syringes and needles are expected to preserve demand. Needleless devices will limit growth in selected applications, but they are not expected to fully displace syringes and needles.

Pricing Pressure in a Mature Market

The syringe and needle market is highly mature and price-sensitive. Many products are standardized, widely available, and purchased in large volumes.

This creates a competitive environment where procurement teams focus heavily on price. Large manufacturers with high production scale have an advantage because they can supply large volumes at lower cost.

As a result, ASP growth remains limited. Even though safety conversion and chronic disease demand support the market, pricing pressure in conventional product categories will continue to constrain value growth.

Market Coverage and Data Scope

• Quantitative coverage: Market size, market shares, market forecasts, market growth rates, units sold, and average selling prices.
• Qualitative coverage: Market drivers and limiters, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios, and leading competitors.
• Time frame: Base year 2025, forecasts to 2032, and historical data back to 2022.
• Market modeling: Revenue is analyzed using unit sales and ASPs, supported by competitive share analysis and forecast assumptions.
• Device scope: The report covers syringes and needles, including conventional syringes, safety syringes, conventional needles, safety needles, and blunt fill needles.

Markets Covered and Segmentation

Syringe and Needle Market

• Device type: Syringes and needles.

The syringe segment includes conventional and safety syringes. Conventional syringes remain widely used in cost-sensitive settings and routine applications where safety-engineered products are not mandated or required.

Safety syringes include built-in safety mechanisms intended to reduce needlestick injury risk. These products are more commonly used in acute care and regulated healthcare settings and typically command higher ASPs than conventional syringes.

The needle segment includes conventional needles, safety needles, and blunt fill needles. Conventional needles remain important because of their low cost and broad use across routine injection and preparation workflows.

Safety needles are designed to reduce needlestick injuries and are commonly used in settings with strong occupational safety requirements. Blunt fill needles are used in medication preparation and help reduce sharp-related risk during filling and transfer workflows.

Each segment is analyzed by market size, market shares, market forecasts, market growth rates, units sold, and average selling prices.

This segmentation helps manufacturers, investors, and strategy teams understand how safety conversion, conventional product demand, chronic disease trends, procurement pressure, and needleless alternatives are shaping the global syringe and needle market.

Competitive Analysis

In 2025, Becton Dickinson led the total syringe and needle market. The company's leadership was strongest in the hospital segment, where it generated more than half of its sales.

BD's production scale allows the company to offer syringes at lower costs while maintaining a broad product portfolio. This scale is important in a market where high-volume supply, pricing, and procurement relationships are central to competitive success.

BD's product range includes SafetyGlide(TM) shielding hypodermic needles, Eclipse(TM) pivoting injection needles, and Integra(TM) retractable syringes. These products support the company's presence in safety-engineered injection devices.

Terumo was the second-leading competitor in the global syringe and needle market. The company is supported by a broad portfolio of conventional and safety-engineered injection products.

Key brands include Terumo(R) Syringes, SurGuard(R) safety needles, and Terumo's hypodermic needle lines. These products are widely used across hospitals, outpatient care, and vaccination programs.

Terumo's strength lies in high-volume manufacturing, consistent product quality, and strong penetration in Asia-Pacific and other global markets. This reinforces its position in a largely price-driven segment.

B. Braun was the third-leading competitor in 2025. The company has gained significant market share in recent years, especially in regions such as Germany, France, and the United Kingdom. B. Braun manufactures standard and fine-dose two-part and three-part syringes.

Technology and Practice Trends

Safety-Engineered Syringes

Safety-engineered syringes continue to shape market value. These products are designed to reduce needlestick injury risk and support compliance with occupational safety standards.

Their higher ASPs help support market value compared with conventional syringes.

Safety Needles

Safety needles remain important in hospitals and other regulated healthcare settings. Products with shielding, pivoting, or retractable mechanisms help reduce injury risk after use.

Adoption is strongest where legislation and inspection have accelerated safety conversion.

Needleless Connectors

Needleless connectors are increasingly used in vascular access. These systems allow medication administration through Luer-lock connections without a traditional needle.

Their use limits demand for certain needle applications but does not eliminate the need for syringes.

Closed IV Delivery Platforms

Closed IV delivery platforms are part of the broader effort to reduce needlestick exposure and improve medication delivery safety.

These systems can replace some manual needle-based workflows in inpatient settings.

Pump-Based Delivery

Pumps increasingly replace manual syringe delivery where feasible. This can reduce reliance on syringes in certain infusion workflows.

However, syringes remain essential for many preparation, injection, and administration tasks.

Needle-Free Injection Research

Needle-free injection technologies, including gas-powered and jet-based systems, continue to be researched. These technologies could reduce needle use in selected areas.

However, broad replacement has not occurred due to cost, workflow, reliability, and familiarity advantages of traditional syringes and needles.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

• How large is the global syringe and needle market today, and how much is it expected to grow through 2032?
• How are syringes and needles performing across the forecast period?
• How are unit sales, ASPs, and market values changing over time?
• What role does safety conversion play in supporting market value growth?
• How are needlestick prevention regulations affecting product adoption?
• How is rising disease incidence, including diabetes and cancer, shaping demand?
• Why do GPOs place strong pressure on syringe and needle pricing?
• How are needleless connectors, pumps, and closed IV systems affecting future demand?
• Which companies lead the global syringe and needle market?
• How are BD, Terumo, and B. Braun positioned across conventional syringes, safety syringes, conventional needles, safety needles, and blunt fill needles?

The Global Syringe and Needle Market Report from iData Research answers these questions with device-level analysis, ASP data, company share insights, and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand safety conversion, and support commercial planning in the global syringe and needle market.